Nuvectis Pharma, Inc.(NVCT)

Biotechnology · Fort Lee, NJ

$20.03-1.36 (-6.36%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Nuvectis Pharma (NVCT) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T22:18:04.596Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:18:04.596Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -1.31
Quote price: 20.03

FMP input reference: b447d722f006e82d19b5d98ef6acffd249f934693947ae19b5e437b2b2585766

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

NVCT Earnings Yield Metrics

EARNINGS YIELD

N/A

NVCT Competitors' Earnings Yield

NVCT

Nuvectis Pharma, Inc.

Current

Market Cap

$531.52M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCTH

Delcath Systems, Inc.

vs NVCT

Market Cap

$531.98M

Earnings Yield

0.08%

TTM Avg

0.28%

3Y Avg

0.28%

5Y Avg

0.28%

MNPR

Monopar Therapeutics Inc.

vs NVCT

Market Cap

$533.04M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STTK

Shattuck Labs, Inc.

vs NVCT

Market Cap

$529.58M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PROK

ProKidney Corp.

vs NVCT

Market Cap

$538.01M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMMX

Immix Biopharma, Inc.

vs NVCT

Market Cap

$524.43M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALT

Altimmune, Inc.

vs NVCT

Market Cap

$519.25M

Earnings Yield

N/A

TTM Avg

516.44%

3Y Avg

516.44%

5Y Avg

516.44%

ACRS

Aclaris Therapeutics, Inc.

vs NVCT

Market Cap

$516.76M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHAT

Phathom Pharmaceuticals, Inc.

vs NVCT

Market Cap

$548.51M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MASS

908 Devices Inc.

vs NVCT

Market Cap

$505.87M

Earnings Yield

N/A

TTM Avg

8.34%

3Y Avg

8.34%

5Y Avg

8.34%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Nuvectis Pharma, Inc. (NVCT)	$531.52M	N/A	N/A	N/A	N/A
Delcath Systems, Inc. (DCTH)vs ›	$531.98M	0.08%	0.28%	0.28%	0.28%
Monopar Therapeutics Inc. (MNPR)vs ›	$533.04M	N/A	N/A	N/A	N/A
Shattuck Labs, Inc. (STTK)vs ›	$529.58M	N/A	N/A	N/A	N/A
ProKidney Corp. (PROK)vs ›	$538.01M	N/A	N/A	N/A	N/A
Immix Biopharma, Inc. (IMMX)vs ›	$524.43M	N/A	N/A	N/A	N/A
Altimmune, Inc. (ALT)vs ›	$519.25M	N/A	516.44%	516.44%	516.44%
Aclaris Therapeutics, Inc. (ACRS)vs ›	$516.76M	N/A	N/A	N/A	N/A
Phathom Pharmaceuticals, Inc. (PHAT)vs ›	$548.51M	N/A	N/A	N/A	N/A
908 Devices Inc. (MASS)vs ›	$505.87M	N/A	8.34%	8.34%	8.34%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

NVCT Earnings Yield Metrics

NVCT Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics